TP53 and cancer: To test whether H203 could induce the p53 pathway in vivo by inhibiting MdmX binding to p53, we treated three cancer cell lines expressing wild-type p53, HCT116, RKO, and H460a, with H203 for 8 h and measured the expression of the p53 and p21 genes (Fig. 9a).